Cancer-Net PCa-MultiSeg: Multimodal Enhancement of Prostate Cancer Lesion Segmentation Using Synthetic Correlated Diffusion Imaging
Keywords: prostate cancer, medical image segmentation, synthetic correlated diffusion imaging, multiparametric MRI, deep learning
TL;DR: CDI$^s$ provides a simple drop-in enhancement that reliably improves prostate cancer lesion segmentation across diverse deep learning architectures, without requiring additional scan time or model modifications.
Track: Findings
Abstract: Current deep learning approaches for prostate cancer lesion segmentation achieve limited performance, with Dice scores of 0.32 or lower in large patient cohorts. To address this limitation, we investigate synthetic correlated diffusion imaging (CDI$^s$) as an enhancement to standard diffusion-based protocols. We conduct a comprehensive evaluation across six state-of-the-art segmentation architectures using 200 patients with co-registered CDI$^s$, diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) sequences. We demonstrate that CDI$^s$ integration reliably enhances or preserves segmentation performance in 94\% of evaluated configurations, with individual architectures achieving up to 72.5\% statistically significant relative improvement over baseline modalities. CDI$^s$ + DWI emerges as the safest enhancement pathway, achieving significant improvements in half of evaluated architectures with zero instances of degradation. Since CDI$^s$ derives from existing DWI acquisitions without requiring additional scan time or architectural modifications, it enables immediate deployment in clinical workflows. Our results establish validated integration pathways for CDI$^s$ as a practical drop-in enhancement for PCa lesion segmentation tasks across diverse deep learning architectures.
General Area: Models and Methods
Specific Subject Areas: Medical Imaging, Supervised Learning, Evaluation Methods & Validity
Data And Code Availability: Yes
Ethics Board Approval: No
Entered Conflicts: I confirm the above
Anonymity: I confirm the above
Submission Number: 206
Loading